These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3856048)

  • 1. Response to doxorubicin of cultured normal and cancerous human mammary epithelial cells.
    Smith HS; Lippman ME; Hiller AJ; Stampfer MR; Hackett AJ
    J Natl Cancer Inst; 1985 Feb; 74(2):341-7. PubMed ID: 3856048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of cells cultured from human mammary carcinomas for studies of malignant progression and chemotherapeutic drug sensitivity.
    Smith HS; Hackett AJ
    J Lab Clin Med; 1987 Mar; 109(3):236-43. PubMed ID: 3819571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of cultured normal human mammary epithelial cells to X rays.
    Yang TC; Stampfer MR; Smith HS
    Radiat Res; 1983 Dec; 96(3):476-85. PubMed ID: 6657917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential sensitivities of human testicular and bladder tumor cell lines to chemotherapeutic drugs.
    Walker MC; Parris CN; Masters JR
    J Natl Cancer Inst; 1987 Aug; 79(2):213-6. PubMed ID: 3474453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Human tumor clonogenic assay in human breast cancer].
    Kobayashi T; Kuraishi Y; Aiba K; Inoue K
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1566-72. PubMed ID: 3927846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalization of in vitro sensitivity testing of human tumor clonogenic cells.
    Hug V; Thames H; Blumenschein GR; Spitzer G; Drewinko B
    Cancer Res; 1984 Mar; 44(3):923-8. PubMed ID: 6692414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug and hormone sensitivity of estrogen receptor-positive and -negative human breast cancer cells in vitro.
    Goldenberg GJ; Froese EK
    Cancer Res; 1982 Dec; 42(12):5147-51. PubMed ID: 7139616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation of adriamycin-resistant cells using multicellular tumor spheroid].
    Sasaki K; Iwata M; Hachiya S; Yuhas JM
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2423-4. PubMed ID: 6639103
    [No Abstract]   [Full Text] [Related]  

  • 9. [In vitro culture of clonogenic cells from various human tumors: chemosensitivity tests].
    Bénard J; Riou G
    Bull Cancer; 1984; 71(4):287-91. PubMed ID: 6093913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promotion by prolactin of the growth of human breast neoplasms cultured in vitro in the soft agar clonogenic assay.
    Manni A; Wright C; Davis G; Glenn J; Joehl R; Feil P
    Cancer Res; 1986 Apr; 46(4 Pt 1):1669-72. PubMed ID: 3948157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility of canine tumor stem cells to doxorubicin.
    Macy DW; Ensley BA; Gillette EL
    Am J Vet Res; 1988 Nov; 49(11):1903-5. PubMed ID: 3247915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
    Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin-induced ultrastructural and growth changes in primary cultures of 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
    Safa AR; Tseng MT
    J Natl Cancer Inst; 1983 Mar; 70(3):535-40. PubMed ID: 6403744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media.
    Ethier SP; Mahacek ML; Gullick WJ; Frank TS; Weber BL
    Cancer Res; 1993 Feb; 53(3):627-35. PubMed ID: 8425198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different techniques for drug cytotoxicity evaluation on MCF-7 human breast cancer cell line.
    Leonessa F; Coialbu T; Toma S
    Anticancer Res; 1986; 6(6):1291-6. PubMed ID: 3813485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro drug-sensitivity test using human tumor clonogenic assay in lung cancer patients].
    Ohnoshi T; Hiraki S
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1582-7. PubMed ID: 3927847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of DNA repair protein Rad51 in human tumour cell lines exposed to doxorubicin.
    Koehn H; Magan N; Isaacs RJ; Stowell KM
    Anticancer Drugs; 2007 Apr; 18(4):419-25. PubMed ID: 17351394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonogenic patterns of human pulmonary adenocarcinoma cell lines (PC-9, PC-13 and PC-14) and how they influence the results of test for chemosensitivity to cisplatin in the human tumor clonogenic assay.
    Lee YC; Saijo N; Sasaki Y; Takahashi H; Sakurai M; Ishihara J; Hoshi A; Chen KM; Hamburger AW
    Jpn J Clin Oncol; 1985 Dec; 15(4):637-44. PubMed ID: 4094096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the cytostatic effect of epirubicin and mitoxantrone on native breast carcinoma cells using the ATP tumor chemosensitivity assay].
    Kurbacher CM; Brenne U; Kurbacher JA; Mallmann P; Krebs D
    Zentralbl Gynakol; 1996; 118(5):271-8. PubMed ID: 8701623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update: the M.D. Anderson Cancer Center experience with paclitaxel in the management of breast carcinoma.
    Holmes FA
    Semin Oncol; 1995 Aug; 22(4 Suppl 8):9-15. PubMed ID: 7543702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.